Trial intelligence / Profile preview

Esketamine vs sufentanil combined with propofol for painless gastrointestinal endoscopy

ChiCTR2200063714Phase 4Recruiting

Sponsor
Third People's Hospital of Chengdu
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine in Procedure-related pain during gastrointestinal endoscopy (2 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoints: heart rate, blood pressure and 3 more. Started Jun 2022; status: recruiting.

02

Drugs

esketamine
03

Conditions

Procedure-related pain during gastrointestinal endoscopy

Beyond the preview

Go deeper on ChiCTR2200063714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200063714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call